Medical Devices Startups

A biosciences company combining targeted diagnostics and therapeutic delivery to improve outcomes in oncology.

1 investor

Juniper Biomedical develops minimally invasive implantable medical devices using neuromodulation technology to treat pelvic health conditions. The company addresses unmet clinical needs in urinary incontinence and other pelvic floor disorders for patients and healthcare providers.

1 investor

Kailo Medical develops workflow automation and interoperable reporting systems for diagnostic imaging to reduce manual processes and improve clinician efficiency. The company serves radiology departments and healthcare providers globally.

1 investor

Modulus Housing is a factory-built prefabricated construction company that delivers industrialized micro-infrastructure solutions for rapid deployment across distributed locations in healthcare, food & beverage, EV charging, data centers, and other sectors. The company uses modular volumetric systems and flat-pack kits manufactured off-site to achieve faster project timelines, higher quality standardization, and lower costs compared to traditional on-site construction.

1 investor

Kalexo Bio develops dual-targeting siRNA therapeutics for cardiovascular disease, with a focus on lipid management and atherosclerotic disease prevention. The company's lead program targets genetic drivers of cardiovascular risk to deliver durable risk reduction in patients.

1 investor

Kalogon develops advanced seating technologies, including smart cushions, aimed at improving comfort and health for people who must sit for extended periods. The company draws on clinical research and customer feedback to address the health risks and discomfort associated with prolonged sitting.

1 investor

Kamada is a vertically integrated biopharmaceutical company that develops and manufactures plasma-derived therapeutics for specialty markets. The company commercializes its own branded products including GLASSIA and KEDRAB, as well as acquired hyperimmune products, distributing to over 30 countries globally.

1 investor

Kaminari Medical develops intravascular imaging technology for cardiovascular interventions, using photoacoustic and optical innovations. The company serves interventional cardiologists and vascular surgeons for real-time imaging during catheter-based procedures.

1 investor

Kanjin Therapeutics is a biotechnology startup developing treatments to restore kidney function and address chronic kidney diseases, using a strategy of targeting the liver. Founded as a scientific spinout from Okayama University, it operates across the US and Japan.

1 investor

Kardium develops the Globe Pulsed Field System, an all-in-one cardiac ablation catheter with 122 individually selectable electrodes that combines high-density mapping and pulsed field ablation. It is designed for physicians treating patients with atrial fibrillation.

1 investor

Karkinos offers HPV testing services for cervical cancer screening, delivered through at-home sample collection and laboratory analysis. The test targets women aged 30 and above seeking early detection of cervical cancer risk.

1 investor

Kaster Technologies provides production planning software designed specifically for pharmaceutical manufacturing. The platform addresses real-time scheduling, team alignment, and constraint visibility across sterile injectables, oral solid dose, and biologics production with built-in GMP compliance.

1 investor

QuTEM provides electron microscopy analytics with proprietary software (Gridsee) for quality control of gene therapies, enabling manufacturers to ensure safety and consistency at regulatory and production scale. The company serves pharmaceutical and gene therapy manufacturers navigating commercialization and regulatory approval requirements.

1 investor

KB Medical Group manufactures safety-focused medical devices including diabetes needles and insulin syringes designed to reduce needle stick injuries. The company serves healthcare providers and patients requiring insulin delivery devices.

1 investor

Kebormed develops medical devices spanning multiple medical fields and conditions, working at the intersection of medicine and technology. The company operates in the medtech and digital health space.

1 investor

あっと株式会社 develops and manufactures health screening devices and body constitution improvement equipment for healthcare organizations, pharmaceutical companies, and health product manufacturers. The company also provides consulting services and custom wellness programs for health businesses and medical institutions.

1 investor

Kemtai is a computer vision platform that uses AI to guide patients through home exercises and provide physical therapists with performance data. The platform is designed for physical therapy clinics and patients undergoing rehabilitation or exercise protocols at home.

1 investor

Kent Imaging designs and manufactures near-infrared imaging technology for assessing tissue viability in limb preservation and surgical care. The company serves healthcare systems with patented oxygen imaging solutions for diagnostic assessment.

1 investor

Keranova is a medtech company developing FemtoMatrix, a robotic surgical platform for eye surgery that uses vision, artificial intelligence, and precise robotic movements to automate cataract procedures via laser Photoemulsification. It serves ophthalmic surgeons and healthcare professionals, developed in collaboration with Jean Monnet University in Saint-Étienne and the CNRS.

1 investor

Kernel develops neurotechnology hardware and software to measure and improve brain health through neuroimaging systems and data analysis. The company serves research institutions, clinics, and partners globally.

1 investor

Kesako operates hearing-care services offering free hearing assessments and consultations with certified audiologists, then fits and sells hearing aids with a 30-day free trial on prescription. It serves individuals with hearing needs and, for each hearing aid sold, funds part of a hearing aid through the Audition Solidarité association.

1 investor

Keylika develops a platform synthesis technology for mixed ligand metal complexes to generate organometallic drugs for treating therapeutic conditions including hematology, pain, inflammation, metabolic disorders, infectious diseases, and oncology. The company combines drug development with drug delivery technologies, customizing molecular structure and formulation to optimize clinical outcomes for women, children, elderly, and patients with specific diseases.

1 investor

Keyron develops ForePass, a fully endoscopic, non-invasive and reversible gastric bypass medical device intended to reproduce the effects of metabolic surgery for patients with Class II & III obesity, type 2 diabetes, MASH/NASH, and liver fibrosis. The company targets severe "diabesity" patients who refuse surgery or do not achieve results with drugs, across the US and EU5 markets.

1 investor

Keystone Dental develops wide-diameter dental implant systems for molar replacement, engineered to provide primary stability and preserve bone structure. The company serves dental practitioners and patients requiring posterior tooth restoration.

1 investor